Insights
Insights From Our Experts
Articles
An Innovative Approach to Comprehensive Key Opinion Leader (KOL) Mapping
Traditional key opinion leader (KOL) mapping techniques are heuristic and often haphazard: EVERSANA™ has developed an innovative and robust approach that dramatically improves results. We base our ability to identify and prioritize KOLs across disease areas…
Evolution of Integrated Mental Health Treatment Models in Southeast Asia (SEA)
Implement Mental Health Integrated Care Models with A Trusted Partner Integrated-care models for mental health conditions implemented in China and Japan have demonstrated the efficacy and cost-effectiveness of such models. SEA is the next frontier of…
Challenges of Scaling Up Cell Therapy to New Geographies
Cell therapy has emerged as one of the most promising disruptive innovations in the pharmaceutical industry. However, despite its commercial promise, companies developing cell therapies have not been able to take full advantage of its massive…
Booming but Constrained: Digital Therapeutics for Mental Health in APAC
Digital therapeutics (DTx) are a fast-emerging class of therapies that use software to treat disease, both as standalone treatments and for treatment optimization. Applications range from improving patient adherence to supporting physicians in managing patients remotely.…
Need for RWE in Consumer Health and Its Impact in Managing Lifecycle of Consumer Health Products
Healthcare has never been more important to the world than in the past two years and it will remain central during the economic recovery. The pandemic’s impact on medical and healthcare systems has emphasized the value…
New Medicines, New Access, New Frontiers
How psychedelics, cell therapies and other innovations are driving regulatory reform and new patient access Science is improving exponentially. What’s now possible, through new medicines, and entirely new categories of medicine, could only be dreamt of…
KAM Reimagined: Building a Strategic Framework to Empower Key Account Management
Key account management (KAM), as a more innovative approach to pharmaceutical sales and account engagement, promises to deliver long-term, mutually beneficial partnerships between biopharmaceutical manufacturers, healthcare systems and provider practices (AKA target accounts). These partnership structures…
Operational Concerns for Key Enacted and Proposed Changes Under Medicare and Medicaid
EVERSANA’s Mike Kurland, Vice President, Revenue Management & Compliance, delivered a presentation on Operational Concerns for Key Enacted and Proposed Changes Under Medicare and Medicaid at Informa Connect’s Medicaid & Government Pricing Congress. Mike discussed the…
Maximizing Sales Performance Through Mindset Learning
EVERSANA’s Jim Kaveney, Vice President, Training, sat down with Limitless Minds’ Co-Founder, DJ Edison, to discuss the recent partnership between the two organizations. EVERSANA™ and Limitless Minds found a mutual connection concentrated on the importance of…
Overcome In-Licensing Barriers to Increase Throughput of Assets
In-licensing is an important growth channel for pharmaceutical companies as they continue to seek more catalysts for growth. In-licensing is used to expand or consolidate a company’s position in a therapy area but can oftentimes be…